Follow-up of patients from the Coronary Artery Surgery Study (CASS) potentially suitable for percutaneous transluminal coronary angioplasty

David Holmes, Ronald E. Vlietstra, Lloyd D. Fisher, Hugh C. Smith, Michael B. Mock, David P. Faxon, Arthur J. Gosselin, Thomas J. Ryan, Melvin P. Judkins, Mary Pettinger

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

To determine the proper place for percutaneous transluminal coronary angioplasty (PTCA) among the therapeutic options available for patients with coronary heart disease, one must compare the results of PTCA with those obtained by conventional medical and surgical therapy. To develop a cohort comparison group, we interrogated the Coronary Artery Surgery Study (CASS) registry, and patients with proximal discrete subtotal stenosis (70% to 99%) involving the right, left anterior descending, circumflex, or left main coronary artery, singly or with stenoses in two of the three major coronary arteries, were selected; 796 patients (3.7% of all patients enrolled in CASS from 1975 to 1979) met these selection criteria. Surgical therapy was chosen in 53.3%; surgical mortality was low and there was excellent 4-year actuarial survival. There was significant improvement in functional class. Survival was also excellent in medically treated patients. Medically treated patients also had significant improvement in functional class in comparison with baseline values. The data prosented here characterize a cohort group against which the clinical results of PTCA can be evaluated and compared.

Original languageEnglish (US)
Pages (from-to)981-988
Number of pages8
JournalAmerican Heart Journal
Volume106
Issue number5 PART 1
DOIs
StatePublished - Jan 1 1983

Fingerprint

Coronary Balloon Angioplasty
Coronary Vessels
Pathologic Constriction
Survival
Patient Selection
Coronary Disease
Registries
Therapeutics
Mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Follow-up of patients from the Coronary Artery Surgery Study (CASS) potentially suitable for percutaneous transluminal coronary angioplasty. / Holmes, David; Vlietstra, Ronald E.; Fisher, Lloyd D.; Smith, Hugh C.; Mock, Michael B.; Faxon, David P.; Gosselin, Arthur J.; Ryan, Thomas J.; Judkins, Melvin P.; Pettinger, Mary.

In: American Heart Journal, Vol. 106, No. 5 PART 1, 01.01.1983, p. 981-988.

Research output: Contribution to journalArticle

Holmes, D, Vlietstra, RE, Fisher, LD, Smith, HC, Mock, MB, Faxon, DP, Gosselin, AJ, Ryan, TJ, Judkins, MP & Pettinger, M 1983, 'Follow-up of patients from the Coronary Artery Surgery Study (CASS) potentially suitable for percutaneous transluminal coronary angioplasty', American Heart Journal, vol. 106, no. 5 PART 1, pp. 981-988. https://doi.org/10.1016/0002-8703(83)90641-5
Holmes, David ; Vlietstra, Ronald E. ; Fisher, Lloyd D. ; Smith, Hugh C. ; Mock, Michael B. ; Faxon, David P. ; Gosselin, Arthur J. ; Ryan, Thomas J. ; Judkins, Melvin P. ; Pettinger, Mary. / Follow-up of patients from the Coronary Artery Surgery Study (CASS) potentially suitable for percutaneous transluminal coronary angioplasty. In: American Heart Journal. 1983 ; Vol. 106, No. 5 PART 1. pp. 981-988.
@article{a4a25972afa5491f869b5f4da14aecb7,
title = "Follow-up of patients from the Coronary Artery Surgery Study (CASS) potentially suitable for percutaneous transluminal coronary angioplasty",
abstract = "To determine the proper place for percutaneous transluminal coronary angioplasty (PTCA) among the therapeutic options available for patients with coronary heart disease, one must compare the results of PTCA with those obtained by conventional medical and surgical therapy. To develop a cohort comparison group, we interrogated the Coronary Artery Surgery Study (CASS) registry, and patients with proximal discrete subtotal stenosis (70{\%} to 99{\%}) involving the right, left anterior descending, circumflex, or left main coronary artery, singly or with stenoses in two of the three major coronary arteries, were selected; 796 patients (3.7{\%} of all patients enrolled in CASS from 1975 to 1979) met these selection criteria. Surgical therapy was chosen in 53.3{\%}; surgical mortality was low and there was excellent 4-year actuarial survival. There was significant improvement in functional class. Survival was also excellent in medically treated patients. Medically treated patients also had significant improvement in functional class in comparison with baseline values. The data prosented here characterize a cohort group against which the clinical results of PTCA can be evaluated and compared.",
author = "David Holmes and Vlietstra, {Ronald E.} and Fisher, {Lloyd D.} and Smith, {Hugh C.} and Mock, {Michael B.} and Faxon, {David P.} and Gosselin, {Arthur J.} and Ryan, {Thomas J.} and Judkins, {Melvin P.} and Mary Pettinger",
year = "1983",
month = "1",
day = "1",
doi = "10.1016/0002-8703(83)90641-5",
language = "English (US)",
volume = "106",
pages = "981--988",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "5 PART 1",

}

TY - JOUR

T1 - Follow-up of patients from the Coronary Artery Surgery Study (CASS) potentially suitable for percutaneous transluminal coronary angioplasty

AU - Holmes, David

AU - Vlietstra, Ronald E.

AU - Fisher, Lloyd D.

AU - Smith, Hugh C.

AU - Mock, Michael B.

AU - Faxon, David P.

AU - Gosselin, Arthur J.

AU - Ryan, Thomas J.

AU - Judkins, Melvin P.

AU - Pettinger, Mary

PY - 1983/1/1

Y1 - 1983/1/1

N2 - To determine the proper place for percutaneous transluminal coronary angioplasty (PTCA) among the therapeutic options available for patients with coronary heart disease, one must compare the results of PTCA with those obtained by conventional medical and surgical therapy. To develop a cohort comparison group, we interrogated the Coronary Artery Surgery Study (CASS) registry, and patients with proximal discrete subtotal stenosis (70% to 99%) involving the right, left anterior descending, circumflex, or left main coronary artery, singly or with stenoses in two of the three major coronary arteries, were selected; 796 patients (3.7% of all patients enrolled in CASS from 1975 to 1979) met these selection criteria. Surgical therapy was chosen in 53.3%; surgical mortality was low and there was excellent 4-year actuarial survival. There was significant improvement in functional class. Survival was also excellent in medically treated patients. Medically treated patients also had significant improvement in functional class in comparison with baseline values. The data prosented here characterize a cohort group against which the clinical results of PTCA can be evaluated and compared.

AB - To determine the proper place for percutaneous transluminal coronary angioplasty (PTCA) among the therapeutic options available for patients with coronary heart disease, one must compare the results of PTCA with those obtained by conventional medical and surgical therapy. To develop a cohort comparison group, we interrogated the Coronary Artery Surgery Study (CASS) registry, and patients with proximal discrete subtotal stenosis (70% to 99%) involving the right, left anterior descending, circumflex, or left main coronary artery, singly or with stenoses in two of the three major coronary arteries, were selected; 796 patients (3.7% of all patients enrolled in CASS from 1975 to 1979) met these selection criteria. Surgical therapy was chosen in 53.3%; surgical mortality was low and there was excellent 4-year actuarial survival. There was significant improvement in functional class. Survival was also excellent in medically treated patients. Medically treated patients also had significant improvement in functional class in comparison with baseline values. The data prosented here characterize a cohort group against which the clinical results of PTCA can be evaluated and compared.

UR - http://www.scopus.com/inward/record.url?scp=0021085270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021085270&partnerID=8YFLogxK

U2 - 10.1016/0002-8703(83)90641-5

DO - 10.1016/0002-8703(83)90641-5

M3 - Article

C2 - 6227227

AN - SCOPUS:0021085270

VL - 106

SP - 981

EP - 988

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 5 PART 1

ER -